- Home
- CIA vs LRMR Comparison
CIA vs LRMR Comparison
Compare CIA & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIA
- LRMR
- Stock Information
- Founded
- CIA 1969
- LRMR N/A
- Country
- CIA United States
- LRMR United States
- Employees
- CIA N/A
- LRMR N/A
- Industry
- CIA Life Insurance
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- CIA Finance
- LRMR Health Care
- Exchange
- CIA Nasdaq
- LRMR Nasdaq
- Market Cap
- CIA 261.8M
- LRMR 309.8M
- IPO Year
- CIA N/A
- LRMR N/A
- Fundamental
- Price
- CIA $5.59
- LRMR $4.28
- Analyst Decision
- CIA
- LRMR Strong Buy
- Analyst Count
- CIA 0
- LRMR 7
- Target Price
- CIA N/A
- LRMR $18.43
- AVG Volume (30 Days)
- CIA 127.9K
- LRMR 1.3M
- Earning Date
- CIA 11-06-2025
- LRMR 10-29-2025
- Dividend Yield
- CIA N/A
- LRMR N/A
- EPS Growth
- CIA N/A
- LRMR N/A
- EPS
- CIA 0.22
- LRMR N/A
- Revenue
- CIA $245,943,000.00
- LRMR N/A
- Revenue This Year
- CIA $4.22
- LRMR N/A
- Revenue Next Year
- CIA $4.46
- LRMR N/A
- P/E Ratio
- CIA $25.35
- LRMR N/A
- Revenue Growth
- CIA N/A
- LRMR N/A
- 52 Week Low
- CIA $2.90
- LRMR $1.61
- 52 Week High
- CIA $5.95
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- CIA 66.41
- LRMR 62.12
- Support Level
- CIA $5.27
- LRMR $3.84
- Resistance Level
- CIA $5.46
- LRMR $4.26
- Average True Range (ATR)
- CIA 0.16
- LRMR 0.27
- MACD
- CIA -0.02
- LRMR 0.02
- Stochastic Oscillator
- CIA 88.71
- LRMR 98.57
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.